Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.
about
Modelling the course of an HIV infection: insights from ecology and evolutionAccelerated immunodeficiency by anti-CCR5 treatment in HIV infectionAdvances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.Phylodynamics of HIV-1 in lymphoid and non-lymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispeciesUnderstanding the HIV coreceptor switch from a dynamical perspective.Understanding the slow depletion of memory CD4+ T cells in HIV infection.Modeling HIV quasispecies evolutionary dynamics.Diversity of HIV-1 subtype B: implications to the origin of BF recombinantsAnalytical and biological considerations in the measurement of cell-associated CCR5 and CXCR4 mRNA and proteinRelaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell countsStochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc.Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.Distribution of HIV-1 infection in different T lymphocyte subsets: antiretroviral therapy-naïve vs. experienced patients.Persistence and emergence of X4 virus in HIV infection.Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment.Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infectionA quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factors.Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferencesPathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection.Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates.Ecological and evolutionary principles in immunology.CD4+ target cell availability determines the dynamics of immune escape and reversion in vivo.Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, UgandaEmergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort studyA genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.Dynamics of molecular evolution in RNA virus populations depend on sudden versus gradual environmental changeTherapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.Sequencing the Biology of Entry: The Retroviral env Gene.The Hayflick Limit May Determine the Effective Clonal Diversity of Naive T Cells.Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells.High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.Fitness valleys constrain HIV-1's adaptation to its secondary chemokine coreceptor.Modelling the human immune system by combining bioinformatics and systems biology approaches.The R5 to X4 coreceptor switch: a dead-end path, or a strategic maneuver? Lessons from a game theoretic analysis.CD4+ T-cell subsets: what really counts in preventing HIV disease?Limited CD4+ T cell proliferation leads to preservation of CD4+ T cell counts in SIV-infected sooty mangabeys.
P2860
Q26853307-5148B916-FE1A-493D-B71A-06770BB5F4F2Q28475890-90806EE1-A9A6-4EC2-9178-A8A326FE66B7Q30249830-C077C4D3-0A2D-45FE-841B-018B7B33B546Q30834495-8D6D10C4-1E1E-4922-84EF-78A778EA2677Q30931832-44B02E52-17BA-4DE0-A5FC-3D866292C855Q33285394-7C11E119-EB31-4043-AFDB-A1E8B99498ABQ33296550-79EBFEEA-E655-4170-9D60-5D815375E3F9Q33646675-CD44DBA9-1B4B-4591-8615-F9F34AC211C4Q33962644-917AF1DE-DA22-4CE7-B94B-50179F9A37C3Q34328264-35886252-A52F-46B7-987E-0319C83D1672Q34367158-E269622E-6C85-4E44-AC2E-4E8BEE4DFD29Q34699720-F4D74149-9470-4BBA-B5C3-EB3AED9AFC69Q34727711-69D9531E-F9D5-4EE2-A111-15EDCC21212EQ35055322-6792342E-7BFA-4DD1-87EB-48206069B047Q35071940-CC3EA504-2FDE-4A52-9A35-27A332986D36Q35133510-60DE7D59-DF3D-414A-B7C1-D628C05AA8A8Q35185919-27FE5271-0D45-4E2C-98C7-F41E88B45DD2Q35191116-D65591A7-1541-446D-904C-F9B0C1626B96Q35270923-67FD885F-5ECA-46FF-87B8-5E9D24FCADE5Q35826183-01E59354-DB58-477B-B34E-DCAADCF12D1FQ35947091-1D885AE5-47B6-430F-B363-F39FB255742CQ36288974-1936C600-1B5A-453C-A979-82187299E5AAQ36481186-96148B82-9EDE-4A56-93A4-038DD9C6BCACQ36540029-04D28DA5-B284-4A0A-A744-D05347915495Q37034798-7AB41582-82B9-46CC-B3E0-1A0402AA6979Q37048027-CB50BEAE-1A05-4246-ADE5-1720A5A0FB82Q37365672-58605EC7-DF1F-475F-9C87-123D6E9E45A4Q37517645-00787A46-FD46-4A41-8238-ACE5A0A8E936Q37739024-1867F57B-5C62-4E4D-9330-6A5121BEF13AQ38887171-5DD3B0C8-5C31-436D-A0F5-05BDCD1791F7Q39408333-51CC615B-8EE4-4355-B7BE-B71DCD3C21A6Q39422249-D8BA8C7A-292C-4404-BC50-32B1421F7DAAQ39763180-72440D69-F1B5-4D2A-BB23-9E6215DC2082Q39884805-9B6E1609-0DC0-46B2-B3D6-564856DBB058Q40548483-F9B78237-3928-466A-B022-C57AFDD5F803Q42239239-B61C64FA-37CA-422C-83A9-9F28E41899F5Q43168249-8010002D-DD31-475A-A4CE-985292B1CAC5Q51596227-14514D93-DAAA-4823-9A72-2C6507B75072Q51966500-53B22ADC-17EA-407E-B6B0-4C1003A82A40Q55479933-5194A6CA-60D6-44C6-A107-9E525E667FC7
P2860
Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Naïve and memory cell turnover ...... e 1: implications for therapy.
@ast
Naïve and memory cell turnover ...... e 1: implications for therapy.
@en
Naïve and memory cell turnover ...... e 1: implications for therapy.
@nl
type
label
Naïve and memory cell turnover ...... e 1: implications for therapy.
@ast
Naïve and memory cell turnover ...... e 1: implications for therapy.
@en
Naïve and memory cell turnover ...... e 1: implications for therapy.
@nl
prefLabel
Naïve and memory cell turnover ...... e 1: implications for therapy.
@ast
Naïve and memory cell turnover ...... e 1: implications for therapy.
@en
Naïve and memory cell turnover ...... e 1: implications for therapy.
@nl
P2860
P1433
P1476
Naïve and memory cell turnover ...... e 1: implications for therapy.
@en
P2093
Mette D Hazenberg
Miles P Davenport
P2860
P304
P356
10.1128/JVI.80.2.802-809.2006
P407
P577
2006-01-01T00:00:00Z